H4P
Halal for Pharma
Market & Industry Analytics

The Global Halal Pharmaceutical Market Size and Trends

By Faiz Azizan (PhD) |
Technical Peer-Review: Verified against JAKIM MS 2424:2019, MPPHM 2020 & PIC/S GMP PE 009-17 by MIHA Certified Lead Auditors.

Market-size numbers for halal pharma differ by about fifty times between reports. Some count only certified medicines. Others include supplements, vaccines and cosmetics.

This article puts the published estimates side by side and explains the drivers. For planning, cite a named, dated report and note its definition.

Published estimates

Halal pharmaceutical market estimates (all paid-report summaries; definitions differ)
SourceBase valueForecastGrowth
Global Info ResearchUS$403.2 million (2023)US$900.1 million by 2030CAGR 12.2%
Intel Market Research (as summarised)US$454.0 million (2024)US$1.09 billion by 2032CAGR 13.8%
Polaris Market ResearchUS$23.28 billion (2024)US$205.30 billion by 2034CAGR 24.39% (2025–2034)
MarketsandMarkets (halal empty capsules only)US$1.19 billion (2024)Forecast to 2029CAGR 5.4%

The first two are broadly consistent: a market of high hundreds of millions of dollars, growing at low double digits. Polaris is a large outlier, likely using a wider definition. The capsule row is a segment, not the whole market, and shows that one input alone can exceed a narrow market estimate.

Several of these are paid reports whose methodology was not visible. Treat them as ranges, not facts.

Demand drivers

Pew Research puts the Muslim population at about 2.0 billion in 2020, up from 1.7 billion in 2010. Its 2015 projection estimated about 2.8 billion, or 30% of the world, by 2050, though those projections predate the 2020 data. Read our foundational analysis on the importance of halal medicine in modern healthcare.

Regulation is the other driver. Indonesia’s phased certification reaches health supplements first and prescription drugs by 2034, with some deadlines reported extended in October 2026. As documented in the industry market guides on Get Halal Malaysia, securing JAKIM certification serves as the gold-standard passport for bilateral trade across OIC and ASEAN member states. See our comparative breakdown of global halal pharmaceutical regulators.

Market drivers and what they mean
DriverEffect on market
Muslim population growthLarger addressable patient base
Mandatory certification schemes (Indonesia)Forces manufacturer compliance and supplier verification
Consumer awarenessMore patients ask about ingredients
Trade and recognition agreementsEasier cross-border supply
Ingredient innovationMore plant-based and recombinant options

Key players

MIDA names Duopharma Biotech, Pharmaniaga and Ain Medicare as leading Malaysian halal pharmaceutical players, and notes Pharmaniaga and CCM have exported halal medicines. In Indonesia, Bio Farma’s IndoVac is described as the first officially halal-certified Covid-19 vaccine. Pharmaniaga has announced a halal vaccine and insulin ambition, though operating status was not confirmed in the sources reviewed.

Selected players (not a ranking)
CompanyCountryHalal angle
Duopharma BiotechMalaysiaFacilities stated to adhere to MS 2424:2019 and SMIIC 50-1
PharmaniagaMalaysiaExports halal medicines; halal vaccine and insulin plans announced
Ain MedicareMalaysiaNamed by MIDA among leading halal pharma players
CCMMalaysiaHalal medicine exports; reported first halal-certified prescription medicine
Bio FarmaIndonesiaIndoVac, described as first officially halal-certified Covid-19 vaccine

Traceability is becoming a baseline. Buyers want digital records back to the origin of each excipient.

Plant-based capsules and recombinant biologics reduce animal-origin issues. Halal logistics is also maturing, see our guide on halal logistics and warehousing solutions. Reliance on imports is a constraint in some markets, as Salaam Gateway has reported for Indonesia. For enterprises seeking to capture supplement market share, explore our advisory for nutraceuticals and softgel halal consulting.

Opportunities and risks
AreaOpportunityRisk
ManufacturersAccess to new marketsCost of segregation and audits
Ingredient suppliersHalal-verified gradesDocumentation burden
Logistics providersHalal cold chain servicesSegregation capital
RegulatorsClear assurance frameworkDivergent national rules

How to use market data

Pick named, dated reports and check how they define “halal pharmaceutical”. Compare at least two sources.

Do not mix figures from different definitions in one forecast. When presenting to investors or regulators, show the range and the definition, not one number.

How to build your own market model

Instead of picking one headline number, build a bottom-up estimate. It is slower but defensible.

Bottom-up market sizing steps (method outline)
StepActionSource type
1Define the scope: certified medicines only, or also supplements and vaccinesYour own definition
2Choose target markets and count the Muslim population in eachCensus and Pew data
3Estimate the pharmaceutical spend per capita in each marketNational health statistics
4Apply a plausible halal-certified share with low, base and high casesRegulator data and expert interviews
5Cross-check against published reports and explain the gapPaid reports

Reading a market report critically

Paid reports differ because of choices that are usually buried. Look for the definition of halal pharmaceutical, the base year, whether the figure is revenue or retail value, the treatment of supplements and vaccines, and the source of the growth rate. A report that does not state these should not be the only source in a business case.

Questions to ask of any market report
QuestionWhy it matters
What is included in the definition?Scope can change the figure by orders of magnitude
What is the base year and currency?Avoids mixing years and currencies
Revenue or retail value?Retail value is much larger than manufacturer revenue
How were the growth rates derived?Method affects credibility
Is the data primary or modelled?Modelled data compounds assumptions

Scenarios for the next five years

Rather than predict one outcome, plan for three. In a regulation-led scenario, mandatory certification spreads and compliance drives growth. In a demand-led scenario, consumer awareness drives voluntary certification. In a constrained scenario, import reliance and compliance costs slow expansion. Each scenario implies different investments in segregation, supplier development and certification.

For the regulatory landscape, see our guide to international halal pharma regulators. For cold chain and supply chain integrity, see halal cold chain and logistics. To prepare your facility for global tender compliance, explore our consulting for prescription medicines and solid dosages certification.

Educational content only. Figures are as published by the sources named, not independently verified.

FA

Faiz Azizan (PhD)

SEO Author & Researcher

Work as SEO author & researcher for halalforpharma.com with Google KG. Contact via LinkedIn or web: drfaizazizan.com.

Regulatory References & Sources

Regulations, National Fatwa Council rulings, and NPRA guidelines evolve. Confirm current validity with JAKIM or MNS Modulaz before altering manufacturing batches.

Frequently Asked Questions

How big is the halal pharmaceutical market?

Estimates vary by about 50 times. Global Info Research values it at US$403.2 million in 2023, rising to US$900.1 million by 2030. Intel Market Research says US$454.0 million in 2024. Polaris Market Research says US$23.28 billion in 2024. The difference is mainly definition and method.

Why do estimates differ so much?

Reports define 'halal pharmaceutical' differently. Some count only certified prescription and OTC medicines. Others include supplements, vaccines, cosmetics or the entire value of medicines sold in Muslim-majority markets.

What drives demand for halal medicine?

A large Muslim population (about 2.0 billion in 2020 per Pew), mandatory certification in Indonesia, rising consumer awareness, and manufacturers seeking market access.

Who are the top halal pharma companies?

MIDA names Duopharma Biotech, Pharmaniaga and Ain Medicare among Malaysia's leading players. Bio Farma in Indonesia is associated with IndoVac. There is no standard ranking, so check each company's current certificates.

What is the future of halal healthcare?

Expect more certification mandates, better traceability, and more plant-based and recombinant ingredient options. Growth is also constrained by import reliance in some markets.

Related Guides & Technical Standards